Eurofins MWG Operon Quality Assurance Group Completes ISO Certifications for Their New Overnight Sequencing Lab

Huntsville, AL (PRWEB) May 30, 2013

Eurofins MWG Operon, Inc. announces that its quality management system has achieved certification to two ISO standards by BSI Group America Inc. for their new Louisville, KY facility. To date, Eurofins MWG Operon is the only DNA sequencing provider offering overnight sequencing with all their functioning laboratories certified to these quality assurance ISO standards.

ISO 9001:2008 specifies requirements for a quality management system that consistently provides products and services that meet customer and regulatory requirements. Certification to this standard demonstrates the commitment of Eurofins MWG Operon to enhancing customer satisfaction and continuously improving all processes.

ISO 13485:2003, specifies requirements for a quality management system that consistently provides medical devices and related services that meet customer and regulatory requirements specific to this industry.

“Our commitment to the continuous improvement of our processes and to customer satisfaction is once again highlighted through our efforts to expand these quality assurance certifications to our new sequencing facility,” stated Martin Kunz, CEO of Eurofins MWG Operon, Inc. “These certifications are important step in the expansion of Eurofins MWG Operon products and services into the diagnostics market.”

Patricia Buck, Director of Quality for Eurofins MWG Operon added, “ISO 9001:2008 and ISO 13485:2003 certifications for our Louisville laboratories now provide an added level of assurance to all our overnight and large project DNA sequencing customers that their samples are handled under rigorous quality standards.”

The certificates can be viewed and downloaded at http://www.operon.com/company/certificates.aspx

About Eurofins MWG Operon
Eurofins MWG Operon, a member of the Eurofins Group with major offices and production facilities in the United States, Europe, and Asia, is an international provider of DNA sequencing services, DNA synthesis products, and bioinformatics services for academic and industrial research. The company’s strengths are its strong customer orientation, fast service, and high quality. For additional information, please visit our website at: operon.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10781900.htm